Compare ALEMBIC PHARMA with FDC - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs FDC - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA FDC ALEMBIC PHARMA/
FDC
 
P/E (TTM) x 16.4 21.3 76.9% View Chart
P/BV x 6.5 4.1 158.1% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 ALEMBIC PHARMA   FDC
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-19
FDC
Mar-18
ALEMBIC PHARMA/
FDC
5-Yr Chart
Click to enlarge
High Rs664319 208.2%   
Low Rs412164 251.5%   
Sales per share (Unadj.) Rs208.761.6 338.6%  
Earnings per share (Unadj.) Rs31.09.9 311.6%  
Cash flow per share (Unadj.) Rs37.112.0 310.2%  
Dividends per share (Unadj.) Rs5.500-  
Dividend yield (eoy) %1.00-  
Book value per share (Unadj.) Rs144.273.2 197.1%  
Shares outstanding (eoy) m188.52174.40 108.1%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x2.63.9 65.8%   
Avg P/E ratio x17.424.3 71.5%  
P/CF ratio (eoy) x14.520.2 71.8%  
Price / Book Value ratio x3.73.3 113.1%  
Dividend payout %17.70-   
Avg Mkt Cap Rs m101,46142,118 240.9%   
No. of employees `000NA5.5 0.0%   
Total wages/salary Rs m7,4672,167 344.6%   
Avg. sales/employee Rs ThNM1,943.7-  
Avg. wages/employee Rs ThNM391.7-  
Avg. net profit/employee Rs ThNM313.7-  
INCOME DATA
Net Sales Rs m39,34710,751 366.0%  
Other income Rs m94510 18.4%   
Total revenues Rs m39,44111,260 350.3%   
Gross profit Rs m8,7362,267 385.4%  
Depreciation Rs m1,152351 327.9%   
Interest Rs m18414 1,315.0%   
Profit before tax Rs m7,4932,411 310.8%   
Minority Interest Rs m11-5 -225.0%   
Prior Period Items Rs m-930-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,568671 233.5%   
Profit after tax Rs m5,8441,735 336.8%  
Gross profit margin %22.221.1 105.3%  
Effective tax rate %20.927.8 75.1%   
Net profit margin %14.916.1 92.0%  
BALANCE SHEET DATA
Current assets Rs m19,5777,213 271.4%   
Current liabilities Rs m14,8962,104 708.1%   
Net working cap to sales %11.947.5 25.0%  
Current ratio x1.33.4 38.3%  
Inventory Days Days9054 164.7%  
Debtors Days Days4528 163.6%  
Net fixed assets Rs m27,0976,865 394.7%   
Share capital Rs m377175 215.2%   
"Free" reserves Rs m26,81112,586 213.0%   
Net worth Rs m27,18812,761 213.1%   
Long term debt Rs m4,9936 83,216.7%   
Total assets Rs m47,77815,041 317.6%  
Interest coverage x41.7173.2 24.1%   
Debt to equity ratio x0.20 39,058.7%  
Sales to assets ratio x0.80.7 115.2%   
Return on assets %12.611.6 108.5%  
Return on equity %21.513.6 158.1%  
Return on capital %23.619.0 124.5%  
Exports to sales %012.3 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA1,327 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m19,4531,889 1,029.9%   
Fx outflow Rs m6,0650-   
Net fx Rs m13,3881,889 708.8%   
CASH FLOW
From Operations Rs m8,1201,498 541.9%  
From Investments Rs m-7,556201 -3,757.3%  
From Financial Activity Rs m590-1,694 -34.8%  
Net Cashflow Rs m1,15310 11,197.1%  

Share Holding

Indian Promoters % 74.1 68.9 107.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.9 4.7 61.7%  
FIIs % 9.1 7.5 121.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 13.9 19.0 73.2%  
Shareholders   49,328 23,730 207.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   SUN PHARMA  PROCTER & GAMBLE HEALTH  NOVARTIS  UNICHEM LAB  ORCHID PHARMA  

Compare ALEMBIC PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Stove Kraft IPO, Key Q3FY21 Results, and Top Buzzing Stocks Today(Pre-Open)

On Friday, Indian share markets witnessed huge selling pressure and ended deep in the red, amid a global selloff.

Related Views on News

ALEMBIC PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 13.8% (Quarterly Result Update)

Jan 19, 2021 | Updated on Jan 19, 2021

For the quarter ended December 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 13.8% YoY). Sales on the other hand came in at Rs 13 bn (up 8.7% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 30.0% (Quarterly Result Update)

Oct 23, 2020 | Updated on Oct 23, 2020

For the quarter ended September 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 30.0% YoY). Sales on the other hand came in at Rs 15 bn (up 17.4% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

FDC LTD. Announces Quarterly Results (3QFY20); Net Profit Up 67.7% (Quarterly Result Update)

Feb 10, 2020 | Updated on Feb 10, 2020

For the quarter ended December 2019, FDC LTD. has posted a net profit of Rs 733 m (up 67.7% YoY). Sales on the other hand came in at Rs 3 bn (up 26.0% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 33.3% (Quarterly Result Update)

Jan 23, 2020 | Updated on Jan 23, 2020

For the quarter ended December 2019, ALEMBIC PHARMA has posted a net profit of Rs 2 bn (up 33.3% YoY). Sales on the other hand came in at Rs 12 bn (up 18.8% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

FDC LTD. Announces Quarterly Results (2QFY20); Net Profit Up 45.4% (Quarterly Result Update)

Nov 12, 2019 | Updated on Nov 12, 2019

For the quarter ended September 2019, FDC LTD. has posted a net profit of Rs 627 m (up 45.4% YoY). Sales on the other hand came in at Rs 3 bn (up 28.8% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

More Views on News

Most Popular

Time to Book Profits in Pharma Stocks(Fast Profits Daily)

Jan 15, 2021

In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.

Smallcap Stocks: Your Best Bet for 2021 and Beyond(Profit Hunter)

Jan 15, 2021

The pandemic failed to thwart Richa's investing success formula for 2020.

Buzzing Sectors Before Budget 2021(Fast Profits Daily)

Jan 12, 2021

The budget is just a few weeks away. Which stocks can you expect to move? Find out in this video.

Here's Why Smallcaps Could Be Your Best Investment in 2021(Profit Hunter)

Jan 12, 2021

Select smallcaps hold a great potential to become the multibaggers of tomorrow. Here's how you could get in early into these stocks.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Jan 22, 2021 (Close)

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 8-QTR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS